17 percent of patients seeing neurologist travel long distance
Sep 13, 2023
Factors associated with long-distance travel include low neurologist density, rural setting and visits for ALS and nervous system cancer.
Strategies needed to improve delivery of Alzheimer’s disease-modifying therapies
Jan 30, 2024
Models that enable primary care practitioners to diagnose disease and evaluate patients for treatment eligibility would have biggest effect on wait times, the study found.
New drug for Alzheimer’s disease shows promise in phase 3 trial
Sep 28, 2022
Lecanemab is a monoclonal antibody drug designed to target and help remove Alzheimer’s-associated amyloid plaques in the brain.
PET changes similar for Alzheimer’s disease, Down syndrome
Dec 20, 2022
“This study shows that, although there are subtle differences, Alzheimer’s disease pathophysiology is similar among people with Down syndrome and people with autosomal dominant Alzheimer’s...
Second death in trial of experimental Alzheimer’s drug raising concerns
Nov 29, 2022
Doctors suspect that by stripping away amyloid deposits, lecanemab weakens blood vessels and leaves them vulnerable to bleeds.
Appendicular lean mass linked to decrease in Alzheimer’s risk
Jul 10, 2023
A higher appendicular lean mass also was associated with increased cognitive performance.
Intranasal insulin may have pro-cognitive benefits
Jun 30, 2023
Improvement in global cognition was seen for patients with Alzheimer’s disease/mild cognitive impairment, but no effects were seen for healthy individuals or other patient populations.
Light therapy aids psychobehavioral symptoms with Alzheimer’s disease
Dec 08, 2023
Significant benefits were seen for sleep efficacy, depression and agitation.
Routine vaccines can cut risk for later Alzheimer’s disease
Aug 23, 2023
The findings were seen for tetanus and diphtheria, shingles and pneumococcus vaccines.
Instrumental activities of daily living test could ID Alzheimer’s disease
Jun 28, 2023
An association was found between simulated real-life IADL and interactions of amyloid and early tau accumulation in cognitively normal seniors.